Versican Plus DHPPi/L4R ইউরোপীয় ইউনিয়ন - পর্তুগীজ - EMA (European Medicines Agency)

versican plus dhppi/l4r

zoetis belgium sa - esgana canina do vírus, tensão cdv bio 11/a, adenovírus canino tipo 2, tensão cav-2 bio 13, parvovírus canino tipo 2b, tensão cpv-2b bio 12/b, canina, parainfluenza vírus de tipo 2, tensão cpiv-2 bio 15 (todas vivo atenuado), leptospira interrogans do serogrupo australis sorovar bratislava, tensão mslb 1088, l. interrogans sorogrupo icterohaemorrhagiae sorovar icterohaemorrhagiae, tensão mslb 1089, l. interrogans do serogrupo canicola sorovar canicola, tensão mslb 1090, l. kirschneri, o serogrupo grippotyphosa sorovar grippotyphosa, tensão mslb 1091... - ao vivo esgana canina do vírus + live canina, adenovírus + live parainfl.vírus + live parvovírus canino + inativada contra a raiva + inativada leptospira, imunológicos para canidae - cães - imunização ativa de cães de 8-9 semanas de idade:para prevenir a mortalidade e sinais clínicos causados por esgana canina do vírus,para evitar a mortalidade e sinais clínicos causada pelo adenovírus canino tipo 1,para evitar sinais clínicos e reduzir a excreção viral causada pelo adenovírus canino tipo 2,para evitar que os sinais clínicos, leucopoenia e excreção viral causada pelo parvovírus canino,para evitar que os sinais clínicos (nasal e ocular de descarga) e reduzir a excreção viral causada por canina, parainfluenza vírus,para evitar que os sinais clínicos da infecção e excreção urinária causada por l. interrogans do serogrupo australis sorovar bratislava,para evitar que os sinais clínicos e a excreção urinária e reduzir a infecção causada pelo l. interrogans serogroup canicola serovar canicola e l. interrogans do serogrupo icterohaemorrhagie sorovar icterohaemorrhagiae,para evitar que os sinais clínicos e reduzir a infecção e excreção urinária causada por l. interrogans serogroup grippotyphosa serovar grippotyphosa e para prevenir mortalidade, sinais clínicos e infecção causada pelo vírus da raiva.

Nobivac DP Plus ইউরোপীয় ইউনিয়ন - ফিনিশ - EMA (European Medicines Agency)

nobivac dp plus

intervet international b.v. - live attenuated canine distemper virus strain onderstepoort: 105.1 – 106.5 tcid50, live recombinant canine parvovirus strain 630a: 105.1 – 106.7 tcid50 - immunologiset siipikarjalle - dogs (small) - for the active immunisation of puppies from 4 weeks of age onwards to prevent clinical signs and mortality of canine distemper virus infection and canine parvovirus infection and to prevent viral excretion following canine distemper virus infection and following canine parvovirus infection.

Nobivac DP Plus ইউরোপীয় ইউনিয়ন - হাঙ্গেরীয় - EMA (European Medicines Agency)

nobivac dp plus

intervet international b.v. - live attenuated canine distemper virus strain onderstepoort: 105.1 – 106.5 tcid50, live recombinant canine parvovirus strain 630a: 105.1 – 106.7 tcid50 - immunológiai állományok kanidákhoz - dogs (small) - for the active immunisation of puppies from 4 weeks of age onwards to prevent clinical signs and mortality of canine distemper virus infection and canine parvovirus infection and to prevent viral excretion following canine distemper virus infection and following canine parvovirus infection.

Nobivac DP Plus ইউরোপীয় ইউনিয়ন - পর্তুগীজ - EMA (European Medicines Agency)

nobivac dp plus

intervet international b.v. - live attenuated canine distemper virus strain onderstepoort: 105.1 – 106.5 tcid50, live recombinant canine parvovirus strain 630a: 105.1 – 106.7 tcid50 - imunologia para canidae - dogs (small) - for the active immunisation of puppies from 4 weeks of age onwards to prevent clinical signs and mortality of canine distemper virus infection and canine parvovirus infection and to prevent viral excretion following canine distemper virus infection and following canine parvovirus infection.

Nobivac DP Plus ইউরোপীয় ইউনিয়ন - ইতালীয় - EMA (European Medicines Agency)

nobivac dp plus

intervet international b.v. - live attenuated canine distemper virus strain onderstepoort: 105.1 – 106.5 tcid50, live recombinant canine parvovirus strain 630a: 105.1 – 106.7 tcid50 - immunologici per i canidi - dogs (small) - for the active immunisation of puppies from 4 weeks of age onwards to prevent clinical signs and mortality of canine distemper virus infection and canine parvovirus infection and to prevent viral excretion following canine distemper virus infection and following canine parvovirus infection.

Nobivac DHPPi vet. Pulver och vätska till injektionsvätska, suspension সুইডেন - সুইডিশ - Läkemedelsverket (Medical Products Agency)

nobivac dhppi vet. pulver och vätska till injektionsvätska, suspension

intervet international b.v. - hundadenovirus (cav2), stam manhattan lpv3, levande försvagat; hundparainfluensavirus (cpiv), stam cornell, levande försvagat; hundparvovirus, stam 154, levande försvagat; valpsjukevirus (cdv), stam onderstepoort, levande försvagat - pulver och vätska till injektionsvätska, suspension - sorbitol hjälpämne; hundadenovirus (cav2), stam manhattan lpv3, levande försvagat 4 log10 tcid50 aktiv substans; hundparvovirus, stam 154, levande försvagat 7 log10 tcid50 aktiv substans; hundparainfluensavirus (cpiv), stam cornell, levande försvagat 5,5 log10 tcid50 aktiv substans; valpsjukevirus (cdv), stam onderstepoort, levande försvagat 4 log10 tcid50 aktiv substans - hund + hundadenovirus + hundparvovirus + hundparainfluensavirus - hund

Nobivac DHPPi vet. Pulver och vätska till injektionsvätska, suspension সুইডেন - সুইডিশ - Läkemedelsverket (Medical Products Agency)

nobivac dhppi vet. pulver och vätska till injektionsvätska, suspension

omnidea ab - hundadenovirus (cav2), stam manhattan lpv3, levande försvagat; hundparainfluensavirus (cpiv), stam cornell, levande försvagat; hundparvovirus, stam 154, levande försvagat; valpsjukevirus (cdv), stam onderstepoort, levande försvagat - pulver och vätska till injektionsvätska, suspension - sorbitol hjälpämne; hundadenovirus (cav2), stam manhattan lpv3, levande försvagat 4 log10 tcid50 aktiv substans; hundparvovirus, stam 154, levande försvagat 7 log10 tcid50 aktiv substans; valpsjukevirus (cdv), stam onderstepoort, levande försvagat 4 log10 tcid50 aktiv substans; hundparainfluensavirus (cpiv), stam cornell, levande försvagat 5,5 log10 tcid50 aktiv substans - hund + hundadenovirus + hundparvovirus + hundparainfluensavirus - hund

Nobivac DHPPi vet. Pulver och vätska till injektionsvätska, suspension সুইডেন - সুইডিশ - Läkemedelsverket (Medical Products Agency)

nobivac dhppi vet. pulver och vätska till injektionsvätska, suspension

orifarm ab - hundadenovirus (cav2), stam manhattan lpv3, levande försvagat; hundparainfluensavirus (cpiv), stam cornell, levande försvagat; hundparvovirus, stam 154, levande försvagat; valpsjukevirus (cdv), stam onderstepoort, levande försvagat - pulver och vätska till injektionsvätska, suspension - hundparvovirus, stam 154, levande försvagat 7 log10 tcid50 aktiv substans; hundadenovirus (cav2), stam manhattan lpv3, levande försvagat 4 log10 tcid50 aktiv substans; hundparainfluensavirus (cpiv), stam cornell, levande försvagat 5,5 log10 tcid50 aktiv substans; valpsjukevirus (cdv), stam onderstepoort, levande försvagat 4 log10 tcid50 aktiv substans; sorbitol hjälpämne - hund + hundadenovirus + hundparvovirus + hundparainfluensavirus - hund

Nobivac DP Plus ইউরোপীয় ইউনিয়ন - রোমানীয় - EMA (European Medicines Agency)

nobivac dp plus

intervet international b.v. - live attenuated canine distemper virus strain onderstepoort: 105.1 – 106.5 tcid50, live recombinant canine parvovirus strain 630a: 105.1 – 106.7 tcid50 - imunologii pentru canide - dogs (small) - for the active immunisation of puppies from 4 weeks of age onwards to prevent clinical signs and mortality of canine distemper virus infection and canine parvovirus infection and to prevent viral excretion following canine distemper virus infection and following canine parvovirus infection.

Parvoduk ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

parvoduk

merial - levende svækkede muscovy duck parvovirus - immunologicals for aves, duck parvovirus, live viral vacciner - Ænder - aktiv immunisering af ænder for at forhindre dødelighed1 og for at reducere vægttab og læsioner af and-parvovirose og derzsy's sygdom. 1i mangel på maternelt afledte antistoffer.